Fate Therapeutics (FATE) Asset Utilization Ratio (2016 - 2025)
Fate Therapeutics' Asset Utilization Ratio history spans 13 years, with the latest figure at 0.02 for Q4 2025.
- For Q4 2025, Asset Utilization Ratio fell 31.15% year-over-year to 0.02; the TTM value through Dec 2025 reached 0.02, down 31.15%, while the annual FY2025 figure was 0.02, 39.22% down from the prior year.
- Asset Utilization Ratio reached 0.02 in Q4 2025 per FATE's latest filing, up from 0.02 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.2 in Q1 2023 to a low of 0.01 in Q1 2024.
- Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.05 recorded in 2021.
- Peak YoY movement for Asset Utilization Ratio: surged 188.89% in 2023, then tumbled 94.12% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then skyrocketed by 125.9% to 0.13 in 2022, then decreased by 8.58% to 0.12 in 2023, then tumbled by 75.92% to 0.03 in 2024, then crashed by 31.15% to 0.02 in 2025.
- Per Business Quant, the three most recent readings for FATE's Asset Utilization Ratio are 0.02 (Q4 2025), 0.02 (Q3 2025), and 0.02 (Q2 2025).